In this retrospective multi center analysis we studied the effectiveness of TDF monotherapy in patients with HBV monoinfection with respect to virologic parameters and resistance.
Liver function tests and hepatitis B virus (HBV) DNA (Versant 3.0) were assessed bimonthly, whereas adefovir-related mutations were searched by INNO-LiPA assay at baseline and at yearly intervals.